NCT05194215 (ROMAN-AI) is a clinical trial of Ada WRA in Gastrointestinal Issues, sponsored by Ada Health GmbH.

Who is sponsoring NCT05194215?

NCT05194215 is sponsored by Ada Health GmbH.

What drugs are being tested in NCT05194215?

Interventions in NCT05194215: Ada WRA.

What condition does NCT05194215 study?

NCT05194215 studies Gastrointestinal Issues, Respiratory Issues, Cardiovascular Issues, Genitourinary Issues, Musculoskeletal Issues, ENT Issues, Eye Issues, Neurologic Issues, Mental Health Issues.

Is NCT05194215 still recruiting?

NCT05194215 is currently completed. Last updated 13 March 2024.

Last reviewed 2024-03-13 · How we verify

NCT05194215: ROMAN-AI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Real-world Observation of Medical Accuracy of a Novel AI-app

Completed Last updated 13 March 2024

What this trial tests

trial testing Ada WRA in Gastrointestinal Issues in 49 participants. Completed in 30 December 2022.

Timeline

6 January 2022

Primary endpoint
7 July 2022

30 December 2022

Quick facts

Lead sponsor	Ada Health GmbH
Status	Completed
Study type	OBSERVATIONAL
Enrollment	49
Start date	6 January 2022
Primary completion	7 July 2022
Estimated completion	30 December 2022
Sites	1 location across Romania

Drugs / interventions tested

Ada WRA

Conditions studied

Gastrointestinal Issues — all drugs for Gastrointestinal Issues →
Respiratory Issues — all drugs for Respiratory Issues →
Cardiovascular Issues — all drugs for Cardiovascular Issues →
Genitourinary Issues — all drugs for Genitourinary Issues →

Sponsor

Ada Health GmbH

Who can join

Adults 2 Months to 60, any sex, with Gastrointestinal Issues or Respiratory Issues. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the performance of the suggestions made by the WRA by comparing Ada's list of suggested conditions and advice level to usual care and a gold-standard in a Romanian clinical setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ada Health GmbH trials

Trials by the same sponsor.

NCT06846957 — ESSENCE is a Quality Improvement Study That Evaluates the Impact of Ada's AI-powered Core Symptom Assessment Technology · completed
NCT06790069 — Evaluating the Impact of a Symptom Checker on Healthcare-seeking Decisions: a Mixed-Methods Study · completed
NCT04958577 — Clinic Waiting Room-based Study of Swahili Language Artificial Intelligence-driven Symptom Assessments in Tanzanian Prim · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05194215 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ada Health GmbH
Last refreshed: 13 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05194215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing